These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3028975

  • 1. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH, Eggleston M.
    Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
    [Abstract] [Full Text] [Related]

  • 2. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
    Smith BR, LeFrock JL.
    Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
    [Abstract] [Full Text] [Related]

  • 3. beta-Lactamase inhibitors.
    Conner CS.
    Drug Intell Clin Pharm; 1985 Jun; 19(6):475-6. PubMed ID: 2988903
    [Abstract] [Full Text] [Related]

  • 4. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J, Hupková M, Krcméry V.
    Cas Lek Cesk; 1995 Sep 06; 134(17):558-61. PubMed ID: 7553760
    [Abstract] [Full Text] [Related]

  • 5. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE, Gurwith MJ.
    Clin Pharm; 1984 Sep 06; 3(6):591-9. PubMed ID: 6391783
    [Abstract] [Full Text] [Related]

  • 6. Evolution of beta-lactamase inhibitors.
    Rolinson GN.
    Rev Infect Dis; 1991 Sep 06; 13 Suppl 9():S727-32. PubMed ID: 1656513
    [Abstract] [Full Text] [Related]

  • 7. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
    Aronoff SC, Jacobs MR, Johenning S, Yamabe S.
    Antimicrob Agents Chemother; 1984 Oct 06; 26(4):580-2. PubMed ID: 6097169
    [Abstract] [Full Text] [Related]

  • 8. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R, Beale AS, Boon RJ, Griffin KE, Slocombe B, Stokes DH, White AR.
    Am J Med; 1985 Nov 29; 79(5B):13-24. PubMed ID: 3878080
    [Abstract] [Full Text] [Related]

  • 9. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M, Ito T.
    Nihon Rinsho; 1987 Mar 29; 45(3):583-7. PubMed ID: 3037135
    [No Abstract] [Full Text] [Related]

  • 10. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
    Barry AL, Jones RN, Packer RR.
    J Antimicrob Chemother; 1986 Jan 29; 17(1):125-7. PubMed ID: 3005222
    [No Abstract] [Full Text] [Related]

  • 11. Beta-lactamase inhibitors from laboratory to clinic.
    Bush K.
    Clin Microbiol Rev; 1988 Jan 29; 1(1):109-23. PubMed ID: 3060240
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    Mohanty S, Singhal R, Sood S, Dhawan B, Das BK, Kapil A.
    Indian J Med Res; 2005 Nov 29; 122(5):425-8. PubMed ID: 16456257
    [Abstract] [Full Text] [Related]

  • 13. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R, Duval J.
    Pathol Biol (Paris); 1995 Apr 29; 43(4):245-52. PubMed ID: 7567109
    [Abstract] [Full Text] [Related]

  • 14. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
    Jacobs MR, Aronoff SC, Johenning S, Shlaes DM, Yamabe S.
    Antimicrob Agents Chemother; 1986 Jun 29; 29(6):980-5. PubMed ID: 3015017
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
    Holder IA, Vanderpool L, Wesselman J.
    J Burn Care Rehabil; 1985 Jun 29; 6(4):331-4. PubMed ID: 3879938
    [No Abstract] [Full Text] [Related]

  • 16. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP.
    Antibiot Khimioter; 1997 Jun 29; 42(12):29-32. PubMed ID: 9480651
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of YTR 830.
    Jacobs MR, Aronoff SC, Appelbaum PC, Yamabe S.
    J Chemother; 1989 Jun 29; 1(3):151-4. PubMed ID: 2552029
    [Abstract] [Full Text] [Related]

  • 18. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
    Aldridge KE.
    Diagn Microbiol Infect Dis; 1993 Oct 29; 17(3):251-6. PubMed ID: 8112038
    [Abstract] [Full Text] [Related]

  • 19. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar 29; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.